These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 12569968)

  • 21. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Mallin K; Charles C; Martin LK; Black L; Bryde J
    Dermatol Surg; 2005 Mar; 31(3):263-70. PubMed ID: 15841624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study.
    Sadick NS; Faacs
    Dermatol Surg; 2002 Sep; 28(9):817-21. PubMed ID: 12269875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum neurotoxin type B--a rapid wrinkle reducer.
    Jacob CI
    Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overview of Botulinum Toxins for Aesthetic Uses.
    Gart MS; Gutowski KA
    Clin Plast Surg; 2016 Jul; 43(3):459-71. PubMed ID: 27363760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"].
    Gassia V; Beylot C; Béchaux S; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin A: its expanding role in dermatology and esthetics.
    Said S; Meshkinpour A; Carruthers A; Carruthers J
    Am J Clin Dermatol; 2003; 4(9):609-16. PubMed ID: 12926979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.
    Baumann LS; Halem ML
    Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237
    [No Abstract]   [Full Text] [Related]  

  • 28. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oculoplastic experience with the cosmetic use of botulinum A exotoxin.
    Edelstein C; Shorr N; Jacobs J; Balch K; Goldberg R
    Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Botulism toxin in practice].
    Durand A; Serment G
    Ann Readapt Med Phys; 2003 Jul; 46(6):386-8. PubMed ID: 12928147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures.
    Wollina U; Konrad H
    Am J Clin Dermatol; 2005; 6(3):141-50. PubMed ID: 15943491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations.
    Alimohammadi M; Punga AR
    Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29084148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.
    Flynn TC; Clark RE
    Dermatol Surg; 2003 May; 29(5):519-22; discussion 522. PubMed ID: 12752521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin A in the mid and lower face and neck.
    Carruthers J; Carruthers A
    Dermatol Clin; 2004 Apr; 22(2):151-8. PubMed ID: 15222575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commentary: Botulinum toxin in clinical medicine: part II.
    Benedetto AV
    Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
    [No Abstract]   [Full Text] [Related]  

  • 40. Botulinum toxin B: the new option in cosmetic injection.
    Spencer JM
    J Drugs Dermatol; 2002 Jul; 1(1):17-22. PubMed ID: 12847750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.